Respirology最新文献

筛选
英文 中文
Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases. 与系统性红斑狼疮相关的慢性间质性肺病:对 89 个病例的多中心研究。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-03-17 DOI: 10.1111/resp.14703
Lou Deneuville, Arthur Mageau, Marie Pierre Debray, Karim Sacre, Nathalie Costedoat-Chalumeau, Eric Hachulla, Yurdagul Uzunhan, Erwan Le Tallec, Jacques Cadranel, Sylvain Marchand Adam, David Montani, Martine Rémi-Jardin, Martine Reynaud-Gaubert, Gregoire Prevot, Guillaume Beltramo, Bruno Crestani, Vincent Cottin, Raphael Borie
{"title":"Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases.","authors":"Lou Deneuville, Arthur Mageau, Marie Pierre Debray, Karim Sacre, Nathalie Costedoat-Chalumeau, Eric Hachulla, Yurdagul Uzunhan, Erwan Le Tallec, Jacques Cadranel, Sylvain Marchand Adam, David Montani, Martine Rémi-Jardin, Martine Reynaud-Gaubert, Gregoire Prevot, Guillaume Beltramo, Bruno Crestani, Vincent Cottin, Raphael Borie","doi":"10.1111/resp.14703","DOIUrl":"10.1111/resp.14703","url":null,"abstract":"<p><strong>Background and objective: </strong>Chronic interstitial lung disease (ILD) occurs rarely with systemic lupus erythematosus (SLE) as compared with other connective tissue diseases. This multicentric retrospective study of patients with SLE-ILD from the OrphaLung and French SLE networks during 2005-2020 aimed to describe the characteristics of patients with SLE-ILD and analyse factors associated with prognosis.</p><p><strong>Methods: </strong>We analysed data for 89 patients with SLE-ILD (82 women, 92.1%) (median age at SLE diagnosis: 35 years [interquartile range 27-47]). All patients met the 2019 EULAR/ACR criteria for the diagnosis of SLE.</p><p><strong>Results: </strong>Forty two (47.2%) patients were positive for anti-ribonuclear protein antibodies and 45 (50.6%) for anti SSA/Ro antibodies. A total of 58 (65.2%) patients had another connective tissue disease: Sjögren's syndrome (n = 33, 37.1%), systemic sclerosis (n = 14, 15.7%), inflammatory myopathy (n = 6, 6.7%), or rheumatoid arthritis (n = 6, 6.7%). ILD was diagnosed along with SLE in 25 (28.1%) patients and at a median of 6 (0-14) years after the SLE diagnosis. The most frequent CT pattern was suggestive of non-specific interstitial pneumonia (n = 41, 46.0%) with or without superimposed organizing pneumonia. After a median follow-up of 86.5 [39.5-161.2] months, 18 (20.2%) patients had died and 6 (6.7%) underwent lung transplantation. The median 5-year and 10-year transplantation-free survival were 96% (92-100) and 87% (78-97). In total, 44 (49.4%) patients showed ILD progression. Cutaneous manifestations and Raynaud's phenomenon were associated with better survival. Only forced vital capacity was significantly associated with survival and ILD progression.</p><p><strong>Conclusion: </strong>ILD is a rare manifestation of SLE with good overall prognosis but with possible risk of ILD progression. Patients with SLE-ILD frequently have another connective tissue disease.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"713-721"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Winning the Tour de France with endobronchial valve therapy without pulmonary rehabilitation. 在没有肺康复治疗的情况下,使用支气管内瓣膜治疗赢得环法自行车赛。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-06-03 DOI: 10.1111/resp.14769
Charlie Strange, Melinda Talley
{"title":"Winning the Tour de France with endobronchial valve therapy without pulmonary rehabilitation.","authors":"Charlie Strange, Melinda Talley","doi":"10.1111/resp.14769","DOIUrl":"10.1111/resp.14769","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"651-652"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory teletrials-A call for equitable access to clinical trials for people with respiratory conditions. 呼吸系统临床试验--呼吁为呼吸系统疾病患者提供公平的临床试验机会。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-06-24 DOI: 10.1111/resp.14781
Anne E Holland, Anne Woollett, Nicole Goh, Ian Glaspole
{"title":"Respiratory teletrials-A call for equitable access to clinical trials for people with respiratory conditions.","authors":"Anne E Holland, Anne Woollett, Nicole Goh, Ian Glaspole","doi":"10.1111/resp.14781","DOIUrl":"10.1111/resp.14781","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"659-661"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141459014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary Concise Review 2023: Asthma. 2023 年当代简明评论》:哮喘。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-06-28 DOI: 10.1111/resp.14782
John Politis, Philip G Bardin, Paul Leong
{"title":"Contemporary Concise Review 2023: Asthma.","authors":"John Politis, Philip G Bardin, Paul Leong","doi":"10.1111/resp.14782","DOIUrl":"10.1111/resp.14782","url":null,"abstract":"<p><p>Asthma research and management needs to meet the priorities of the end user-patients, carers and clinicians. A better understanding of the natural history of asthma and the progression of disease has highlighted the importance of early identification of patients with asthma and the potential role of early intervention. Management of mild asthma requires a consistent approach with the same detail and consideration used when managing severe disease. Evidence around treatable traits approaches continues to evolve, supporting the role of a personalized medicine in asthma. Oral corticosteroid (OCS) stewardship continues to be an urgent issue in asthma management. Strategies to taper OCS doses and the implementation of biologic therapies for their steroid sparing benefits will be important steps to address this problem. The concept of remission in asthma provides an ambitious target and treatment outcome.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"674-684"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141470498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary Concise Review 2023: Advances in lung cancer and interventional pulmonology. 当代简明评论 2023》:肺癌和介入肺病学的进展。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-07-03 DOI: 10.1111/resp.14789
Tracy L Leong, Daniel P Steinfort
{"title":"Contemporary Concise Review 2023: Advances in lung cancer and interventional pulmonology.","authors":"Tracy L Leong, Daniel P Steinfort","doi":"10.1111/resp.14789","DOIUrl":"10.1111/resp.14789","url":null,"abstract":"<p><p>Eligibility criteria for lung cancer screening increasingly need to consider family history of lung cancer, as well as age and smoking status. Lung cancer screening will reveal a multitude of incidental findings, of variable clinical significance, and with a need for clear pathways of management. Pulmonary nodule sampling is enhanced by intra-procedural imaging and cutting-edge robotic technology. Systematic thoracic lymph node sampling has implications for treatment efficacy. Bronchoscopic ablative techniques are feasible for peripheral lung cancers. Bronchoscopic sampling continues to have a high yield for lung cancer molecular characterization. Immunotherapy indications have expanded to include early stage and resectable lung cancer.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"665-673"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a score model to predict long-term prognosis after community-onset pneumonia in older patients. 建立评分模型,预测老年患者社区发病肺炎后的长期预后。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-05-20 DOI: 10.1111/resp.14752
Takahiro Takazono, Hotaka Namie, Yohsuke Nagayoshi, Yoshifumi Imamura, Yuya Ito, Makoto Sumiyoshi, Nobuyuki Ashizawa, Masataka Yoshida, Kazuaki Takeda, Naoki Iwanaga, Shotaro Ide, Yosuke Harada, Naoki Hosogaya, Shinnosuke Takemoto, Yuichi Fukuda, Kazuko Yamamoto, Taiga Miyazaki, Noriho Sakamoto, Yasushi Obase, Toyomitsu Sawai, Yasuhito Higashiyama, Kohji Hashiguchi, Satoshi Funakoshi, Naofumi Suyama, Hikaru Tanaka, Katsunori Yanagihara, Koichi Izumikawa, Hiroshi Mukae
{"title":"Development of a score model to predict long-term prognosis after community-onset pneumonia in older patients.","authors":"Takahiro Takazono, Hotaka Namie, Yohsuke Nagayoshi, Yoshifumi Imamura, Yuya Ito, Makoto Sumiyoshi, Nobuyuki Ashizawa, Masataka Yoshida, Kazuaki Takeda, Naoki Iwanaga, Shotaro Ide, Yosuke Harada, Naoki Hosogaya, Shinnosuke Takemoto, Yuichi Fukuda, Kazuko Yamamoto, Taiga Miyazaki, Noriho Sakamoto, Yasushi Obase, Toyomitsu Sawai, Yasuhito Higashiyama, Kohji Hashiguchi, Satoshi Funakoshi, Naofumi Suyama, Hikaru Tanaka, Katsunori Yanagihara, Koichi Izumikawa, Hiroshi Mukae","doi":"10.1111/resp.14752","DOIUrl":"10.1111/resp.14752","url":null,"abstract":"<p><strong>Background and objective: </strong>The identification of factors associated with long-term prognosis after community-onset pneumonia in elderly patients should be considered when initiating advance care planning (ACP). We aimed to identify these factors and develop a prediction score model.</p><p><strong>Methods: </strong>Patients aged 65 years and older, who were hospitalized for pneumonia at nine collaborating institutions, were included. The prognosis of patients 180 days after the completion of antimicrobial treatment for pneumonia was prospectively collected.</p><p><strong>Results: </strong>The total number of analysable cases was 399, excluding 7 outliers and 42 cases with missing data or unknown prognosis. These cases were randomly divided in an 8:2 ratio for score development and testing. The median age was 82 years, and there were 68 (17%) deaths. A multivariate analysis showed that significant factors were performance status (PS) ≥2 (Odds ratio [OR], 11.78), hypoalbuminemia ≤2.5 g/dL (OR, 5.28) and dementia (OR, 3.15), while age and detection of antimicrobial-resistant bacteria were not associated with prognosis. A scoring model was then developed with PS ≥2, Alb ≤2.5, and dementia providing scores of 2, 1 and 1 each, respectively, for a total of 4. The area under the curve was 0.8504, and the sensitivity and specificity were 94.6% and 61.7% at the cutoff of 2, respectively. In the test cases, the sensitivity and specificity were 91.7% and 63.1%, respectively, at a cutoff value of 2.</p><p><strong>Conclusion: </strong>Patients meeting this score should be considered near the end of life, and the initiation of ACP practices should be considered.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"722-730"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The challenges facing children with pulmonary tuberculosis-a catastrophe of civil war: Letter from Sudan. 儿童肺结核患者面临的挑战--内战的灾难:苏丹来信。
IF 6.6 2区 医学
Respirology Pub Date : 2024-08-01 Epub Date: 2024-06-19 DOI: 10.1111/resp.14777
Omer Osman Babiker, Esraa Hassan Salih Elhaj, Khabab Abbasher Hussien Mohamed Ahmed
{"title":"The challenges facing children with pulmonary tuberculosis-a catastrophe of civil war: Letter from Sudan.","authors":"Omer Osman Babiker, Esraa Hassan Salih Elhaj, Khabab Abbasher Hussien Mohamed Ahmed","doi":"10.1111/resp.14777","DOIUrl":"10.1111/resp.14777","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"734-735"},"PeriodicalIF":6.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction. 世界支气管和介入肺科协会(WABIP)关于气道支架治疗恶性中央气道阻塞的指南。
IF 6.6 2区 医学
Respirology Pub Date : 2024-07-01 Epub Date: 2024-05-29 DOI: 10.1111/resp.14764
Udit Chaddha, Abhinav Agrawal, Jonathan Kurman, Rosamaria Ortiz-Comino, Herve Dutau, Lutz Freitag, Rocco Trisolini, Christophe Dooms, Lina Zuccatosta, Stefano Gasparini, Felix Herth, Hideo Saka, Pyng Lee, David Fielding, Masahide Oki, Antoni Rosell, Septimiu Murgu
{"title":"World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction.","authors":"Udit Chaddha, Abhinav Agrawal, Jonathan Kurman, Rosamaria Ortiz-Comino, Herve Dutau, Lutz Freitag, Rocco Trisolini, Christophe Dooms, Lina Zuccatosta, Stefano Gasparini, Felix Herth, Hideo Saka, Pyng Lee, David Fielding, Masahide Oki, Antoni Rosell, Septimiu Murgu","doi":"10.1111/resp.14764","DOIUrl":"10.1111/resp.14764","url":null,"abstract":"<p><p>Malignant Central Airway Obstruction (MCAO) encompasses significant and symptomatic narrowing of the central airways that can occur due to primary lung cancer or metastatic disease. Therapeutic bronchoscopy is associated with high technical success and symptomatic relief and includes a wide range of airway interventions including airway stents. Published literature suggests that stenting practices vary significantly across the world primarily due to lack of guidance. This document aims to address this knowledge gap by addressing relevant questions related to airway stenting in MCAO. An international group of 17 experts from 17 institutions across 11 countries with experience in using airway stenting for MCAO was convened as part of this guideline statement through the World Association for Bronchology and Interventional Pulmonology (WABIP). We performed a literature and internet search for reports addressing six clinically relevant questions. This guideline statement, consisting of recommendations addressing these six PICO questions, was formulated by a systematic and rigorous process involving the evaluation of published evidence, augmented with expert experience when necessary. Panel members participated in the development of the final recommendations using the modified Delphi technique.</p>","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"563-573"},"PeriodicalIF":6.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141176226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The challenge of interpreting diminished mid-expiratory flow in the presence of normal FEV1 and FVC. 在 FEV1 和 FVC 正常的情况下解释呼气中流量减少的挑战。
IF 6.6 2区 医学
Respirology Pub Date : 2024-07-01 Epub Date: 2024-05-21 DOI: 10.1111/resp.14756
Andre Gie, Pierre Goussard
{"title":"The challenge of interpreting diminished mid-expiratory flow in the presence of normal FEV<sub>1</sub> and FVC.","authors":"Andre Gie, Pierre Goussard","doi":"10.1111/resp.14756","DOIUrl":"10.1111/resp.14756","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"535-536"},"PeriodicalIF":6.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations from The Medical Education Editor. 医学教育编辑的建议。
IF 6.6 2区 医学
Respirology Pub Date : 2024-07-01 Epub Date: 2024-05-30 DOI: 10.1111/resp.14759
Mark Lavercombe
{"title":"Recommendations from The Medical Education Editor.","authors":"Mark Lavercombe","doi":"10.1111/resp.14759","DOIUrl":"10.1111/resp.14759","url":null,"abstract":"","PeriodicalId":21129,"journal":{"name":"Respirology","volume":" ","pages":"530-532"},"PeriodicalIF":6.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141176224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信